NCT06799923

Brief Summary

Medically intractable tremors are a common difficult clinical situation. Deep brain stimulation decreases Parkinson's disease tremor and essential tremor, but not all patients are candidates from a diagnostic, medical, or social standpoint, prompting the need for alternative surgical strategies. Less invasive lesional brain surgery (thalamotomy) procedures by radio-surgery or MRI-guided focused ultrasound have emerged and have proven to be effective in these third-line indications. Recently, a new technology has emerged allowing the performance of minimally invasive lesion surgeries by MRI-Guided Laser Interstitial Thermal Therapy (MRIg-LITT). MRIg-LITT has been shown to be effective and safe in management of epilepsies and brain tumors. However, no study has evaluated MRIg-LITT for performing thalamotomy in medically intractable tremor.In a pilot study, the investigators propose to evaluate the effect and safety of unilateral thalamotomy by MRIg-LITT in the management of medically intractable tremor of parkinsonian or essential origin.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 24, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 29, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

January 29, 2025

Status Verified

September 1, 2024

Enrollment Period

1.1 years

First QC Date

September 24, 2024

Last Update Submit

January 28, 2025

Conditions

Keywords

laser interstitial thermal therapyParkinson DiseaseEssential TremorMovement DisordersMRI

Outcome Measures

Primary Outcomes (1)

  • Variation of total body weight from baseline

    To assess the impact of UF prescription guided by the ECW/TBWat ratio on weight loss, a comparison of TBW (∆TBW) between the two groups will be conducted. The ∆TBW is the difference between the initial TBW at H0 and the TBW at H72.

    at 72 hours

Secondary Outcomes (1)

  • cumulative fluid balance

    at 72 hours

Study Arms (1)

Parkinson's disease

EXPERIMENTAL

Patients 18 years age or older with Parkinson's disease or essential tremor and tremor resistant to medical therapy with a contraindication to deep brain stimulation or refusal deep brain stimulation

Procedure: laser electrode

Interventions

A laser electrode is implanted surgically in the ventral and inteermediary nucleus of the thalamus (VIM).

Parkinson's disease

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 18 years age or older with Parkinson\'s disease or essential tremor and tremor resistant to medical therapy with a contraindication to deep brain stimulation or refusal deep brain stimulation

You may not qualify if:

  • Contraindication to MRI
  • Contraindication to general anesthesia
  • Patient unable to give their free and informed consent because of cognitive or psychiatric disorders
  • Brain anatomical abnormalities not allowing intervention
  • Adults protected (guardianship, curators) or deprived of liberty.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU Amiens

Salouël, 80480, France

RECRUITING

MeSH Terms

Conditions

Parkinson DiseaseEssential TremorMovement Disorders

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesSynucleinopathiesNeurodegenerative Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 24, 2024

First Posted

January 29, 2025

Study Start

August 1, 2024

Primary Completion

September 1, 2025

Study Completion

April 1, 2026

Last Updated

January 29, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations